Isovorin

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Hokkaido Gastrointestinal Cancer Study Group

Conditions

Colon CancerGastric CancerMetastatic Colorectal Cancer

Phase 3

Study Evaluating Isovorin in Colon Cancer

CompletedNCT00195585

Wyeth is now a wholly owned subsidiary of PfizerColon Cancer

Start: 2002-10-31End: 2006-02-28Target: 650Updated: 2009-08-13

Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer

CompletedNCT00195572

Wyeth is now a wholly owned subsidiary of PfizerGastric Cancer

Start: 2002-05-31End: 2008-08-31Target: 200Updated: 2009-08-13

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

SuspendedNCT00316745

Hokkaido Gastrointestinal Cancer Study GroupMetastatic Colorectal Cancer

Start: 2006-04-30End: 2009-03-31Target: 200Updated: 2007-11-01